After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus. The question is whether this rally marks a real recovery or just another ...

Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Federal funding cuts and threats to higher education are putting key ingredients of Boston’s recipe for biotech success in jeopardy For more than a decade, Boston has been the undisputed capital of ...

Shares of Sana Biotechnology (NASDAQ:SANA) climbed ~24% in the morning hours on Wednesday, triggering several trading halts after Canadian hedge fund manager Eric Jackson said that he is long the ...

Ten months into 2025, and it’s clear the year hasn’t unfolded as many had expected—or hoped. Marked by a persistent bear market and compounded by geopolitical tensions and regulatory uncertainty, the ...

A new RNA biotech has risen with a $200 million series A in the tank and a team of seasoned biotech chefs ready to light the burners. Soufflé Therapeutics will cook up siRNA medicines that are ...

A California scientist and former magician who claimed he had discovered the cure for HIV has been found guilty of orchestrating the murder of a business rival who was found dead in a Vermont snowbank ...

In this article, we will look at the top 14 Biotech Stocks with High Potential. On October 1, Evan Seigerman, head of healthcare research at BMO Capital Markets, appeared on CNBC’s “The Exchange” to ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Benzinga’s Edge Stock Rankings system scores stocks across key measures including momentum, growth, value and quality. The momentum score serves as a key indicator for traders looking to capitalize on ...

Biotech is "at the cusp of a golden age" in the U.S., and Illinois will capitalize on it by taking advantage of the changes on the horizon, like AI and quantum science, said John Crowley, president ...